Enanta Pharmaceuticals (ENTA) Enterprise Value Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.97% |
| Dec 31, 2025 | 4.66% |
| Sep 30, 2025 | 8.83% |
| Jun 30, 2025 | 6.94% |
| Mar 31, 2025 | 11.64% |
| Dec 31, 2024 | 5.78% |
| Sep 30, 2024 | -0.57% |
| Jun 30, 2024 | 3.60% |
| Mar 31, 2024 | 7.21% |
| Dec 31, 2023 | 4.43% |
| Sep 30, 2023 | 39.56% |
| Jun 30, 2023 | -1.47% |
| Mar 31, 2023 | 16.06% |
| Dec 31, 2022 | 16.90% |
| Sep 30, 2022 | 9.41% |
| Jun 30, 2022 | 13.34% |
| Mar 31, 2022 | 8.85% |
| Dec 31, 2021 | 9.18% |
| Sep 30, 2021 | 7.54% |
| Jun 30, 2021 | 2.04% |
| Mar 31, 2021 | -13.56% |
| Dec 31, 2020 | -20.55% |
| Sep 30, 2020 | -20.02% |
| Jun 30, 2020 | -24.44% |
| Mar 31, 2020 | -26.48% |
| Dec 31, 2019 | -21.31% |
| Sep 30, 2019 | -16.86% |
| Jun 30, 2019 | -21.23% |
| Mar 31, 2019 | -18.86% |
| Dec 31, 2018 | -24.35% |
| Sep 30, 2018 | -28.64% |
| Jun 30, 2018 | -21.03% |
| Mar 31, 2018 | -15.77% |
| Dec 31, 2017 | -28.45% |
| Sep 30, 2017 | -35.17% |
| Jun 30, 2017 | -26.04% |
| Mar 31, 2017 | -22.82% |
| Dec 31, 2016 | -31.58% |
| Sep 30, 2016 | -27.45% |
| Jun 30, 2016 | -32.20% |
| Mar 31, 2016 | -26.41% |
| Dec 31, 2015 | -105.47% |
| Sep 30, 2015 | -49.10% |
| Jun 30, 2015 | -238.84% |
| Mar 31, 2015 | -99.94% |